Ever since the establishment of the Jamila Sultan Foundation in 2004, the aim was to provide quality services to maximum thalassemic under a much conducive environment, both for children and their families. We have accepted an upheaval task to provide the best complementary services to all dependent patients, irrespective of their social status by meeting all
The financial needs of Global Pharmaceuticals, implicitly. Alhamd O Lillah, JSF is not only successfully providing the sustained quality services to more than 600 patients but also achieved new heights in terms of modern techniques with state of the art gadgets to deal with the menace of thalassemia.
Indeed, it is a matter of great contentment as chairman that JSF as esteemed institute has extended
Its services to carry out free Serum £-eritin tests of 400 thalassemic patients’ dependent on Holy Family Hospital. During a formal visit of Global Pharma by Dr, Nasir Shah, commandant CEO of NMHRA Afghanistan expressed his interest to extend services for 50 thalassemic patients of Afghanistan by providing all possible financial support, expertise to establish state of the art thalassemia center at Jalalabad. Global Pharma is committed to provide all possible services after formal consent by the govt of Afghanistan.
We bow our heads to Almighty Allah for achieving new heights not only in extending quality services to overwhelming majority of thalassemic children but also exploring new zenith in the field of modern trends to deal w’ith thalassemia. JSP has sponsored Dr, Tanzil (Pathologist) to participate in the 14th International Conference on Thalassemia and hemoglobin pathies and 16th T.I.F International Conference (Joint venture) for Introduction of new modalities of treatment of thalassemia with the vision to “Fight Thalassemia as a National Cause”